[PHARMA] QoQ Cumulative Quarter Result on 31-Dec-2019 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
QoQ- -607.91%
YoY- -451.37%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 2,090,488 1,465,684 819,921 2,820,530 2,104,847 1,387,998 786,108 91.60%
PBT 49,299 45,206 30,880 -191,865 46,609 42,724 30,243 38.38%
Tax -15,983 -13,184 -8,465 42,418 -17,323 -13,814 -10,595 31.43%
NP 33,316 32,022 22,415 -149,447 29,286 28,910 19,648 42.06%
-
NP to SH 33,820 32,378 22,399 -149,219 29,379 28,898 19,617 43.63%
-
Tax Rate 32.42% 29.16% 27.41% - 37.17% 32.33% 35.03% -
Total Cost 2,057,172 1,433,662 797,506 2,969,977 2,075,561 1,359,088 766,460 92.78%
-
Net Worth 345,040 357,891 350,047 336,573 516,387 518,564 528,825 -24.71%
Dividend
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Div 26,139 22,204 15,673 22,177 22,168 22,149 15,630 40.76%
Div Payout % 77.29% 68.58% 69.98% 0.00% 75.46% 76.65% 79.68% -
Equity
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Net Worth 345,040 357,891 350,047 336,573 516,387 518,564 528,825 -24.71%
NOSH 261,705 261,705 261,229 261,229 261,229 261,229 260,505 0.30%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 1.59% 2.18% 2.73% -5.30% 1.39% 2.08% 2.50% -
ROE 9.80% 9.05% 6.40% -44.33% 5.69% 5.57% 3.71% -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 799.75 561.06 313.87 1,081.04 807.07 532.65 301.76 91.17%
EPS 12.94 12.39 8.57 -57.19 11.26 11.09 7.53 43.32%
DPS 10.00 8.50 6.00 8.50 8.50 8.50 6.00 40.44%
NAPS 1.32 1.37 1.34 1.29 1.98 1.99 2.03 -24.88%
Adjusted Per Share Value based on latest NOSH - 261,229
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 145.05 101.70 56.89 195.70 146.05 96.31 54.54 91.61%
EPS 2.35 2.25 1.55 -10.35 2.04 2.01 1.36 43.85%
DPS 1.81 1.54 1.09 1.54 1.54 1.54 1.08 40.95%
NAPS 0.2394 0.2483 0.2429 0.2335 0.3583 0.3598 0.3669 -24.71%
Price Multiplier on Financial Quarter End Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 -
Price 4.32 2.22 1.26 2.06 2.44 2.84 2.27 -
P/RPS 0.54 0.40 0.40 0.19 0.30 0.53 0.75 -19.61%
P/EPS 33.39 17.91 14.69 -3.60 21.66 25.61 30.14 7.04%
EY 2.99 5.58 6.81 -27.76 4.62 3.90 3.32 -6.72%
DY 2.31 3.83 4.76 4.13 3.48 2.99 2.64 -8.49%
P/NAPS 3.27 1.62 0.94 1.60 1.23 1.43 1.12 103.87%
Price Multiplier on Announcement Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 19/11/20 19/08/20 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 -
Price 5.72 4.42 1.88 2.04 2.21 2.66 2.36 -
P/RPS 0.72 0.79 0.60 0.19 0.27 0.50 0.78 -5.18%
P/EPS 44.21 35.66 21.93 -3.57 19.62 23.99 31.34 25.70%
EY 2.26 2.80 4.56 -28.04 5.10 4.17 3.19 -20.47%
DY 1.75 1.92 3.19 4.17 3.85 3.20 2.54 -21.93%
P/NAPS 4.33 3.23 1.40 1.58 1.12 1.34 1.16 140.05%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment